Aledade
Unicorn · $3.5BBethesda, US · Founded 2014 · Delaware corporation · 16 known investors
Aledade is an accountable care organization (ACO) partner that works with primary care organizations to improve patient outcomes and healthcare quality. The company operates as a public benefit corporation focused on supporting member primary care organizations and their patients.
Also known as Aledade, Inc.
Founders & leadership
Aledade was founded in 2014 by Bijan Salehizadeh, Farzad Mostashari, and Mat Kendall.



Board

Investors · 16
Also in the syndicate · 4
Reported raises · per SEC filings
Form D private placements$662.6M disclosed across 8 of 13 rounds · 2014–2025
▶$260MraisedJun 2023 · 11 investors · Other TechnologyRule 506(b)
- Phuong PhillipsExecutive Officer
- Michelle RyanDirector
- John DoyleExecutive Officer
- Paul HennessyDirector
- Farzad MostashariExecutive Officer, Director
- David BlumenthalDirector
- Robert KocherDirector
- Phyllis YaleDirector
- Julie SunderlandDirector
- Bijan SalehizadehDirector
- Matthew KendallExecutive Officer
- Offering amount
- $260M
- Amount sold
- $260M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$122.3MraisedJun 2022 · 20 investors · Other TechnologyRule 506(b)
- Farzad MostashariExecutive Officer, Director
- Kendall MatExecutive Officer
- Bijan SalehizadehDirector
- John DoyleExecutive Officer
- Julie SunderlandDirector
- Phyllis YaleDirector
- Michelle RyanDirector
- Robert KocherDirector
- Offering amount
- $122.3M
- Amount sold
- $122.3M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100MraisedJan 2021 · 10 investors · Other Health CareRule 506(b)
- Mat KendallExecutive Officer
- James ManziDirector
- Julie SunderlandDirector
- Farzad MostashariExecutive Officer, Director
- Robert KocherDirector
- Offering amount
- $100M
- Amount sold
- $100M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$64.4MraisedApr 2020 · 11 investors · Other Health CareRule 506(b)
- Farzad MostashariExecutive Officer, Director
- Charles ColliganExecutive Officer
- James ManziDirector
- Patrick ConwayDirector
- Julie SunderlandDirector
- Robert KocherDirector
- Offering amount
- $77.2M
- Amount sold
- $64.4M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$56.1MraisedJan 2019 · 17 investors · Other Health CareRule 506(b)
- Julie SunderlandDirector
- Farzad MostashariExecutive Officer, Director
- Charles ColliganExecutive Officer
- Robert KocherDirector
- James ManziDirector
- Offering amount
- $56.1M
- Amount sold
- $56.1M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$40.2MraisedMar 2017 · 11 investors · Other Health CareRule 506(b)
- Robert KocherDirector
- Mark McClellanDirector
- Stephen B. ThauExecutive Officer
- Farzad MostashariExecutive Officer, Director
- Julie SunderlandDirector
- Offering amount
- $40.2M
- Amount sold
- $40.2M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedJun 2015 · 7 investors · Other Health CareRule 506(b)
- Robert KocherDirector
- Farzad MostashariExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $15M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$4.5MraisedJun 2014 · 5 investors · Other Health CareRule 506(b)
- Robert KocherDirector
- Farzad MostashariExecutive Officer, Director
- Stephen B. ThauExecutive Officer
- Offering amount
- $5.5M
- Amount sold
- $4.5M
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Company profile
researched Aug 2026Aledade is a Bethesda, Maryland-based health care technology company that organizes and operates accountable care organizations (ACOs) for primary care organizations, including independent practices, community health centers and health systems. It supplies data analytics, software, workflow tools, coaching and administrative support so that clinicians can adopt value-based care while remaining independent, and it holds contracts with Medicare, Medicaid and commercial payers under which participating practices earn shared savings.
The company's offerings are grouped into a technology platform that centralizes and surfaces patient data at the point of care, expert support and coaching, practice resources covering contracting and financial/operational support, and patient engagement solutions. Additional programs include Aledade FIRST, a value-based care curriculum for PGY2 and PGY3 primary care residents that includes subsidized clinical rotations, job placement with partner practices and financial incentives of up to $60,000 aligned with loan-forgiveness programs; a turnkey program in select states to help clinicians start an independent practice; and the Aledade Policy Institute, which conducts state and national policy advocacy. Aledade Access is a Medicare-covered, physician-referred remote monitoring and coaching program for patients with high blood pressure, high cholesterol, high blood sugar or early kidney disease that provides a connected blood pressure cuff at no cost to the patient; participation is tied to a federal payment model test run by CMS in which some beneficiaries are randomly assigned to a comparison group.
Aledade is structured as a public benefit corporation and describes itself as the largest network of independent primary care practices in the United States. A third-party profile also notes integrations with over 100 EHRs and more than 300 external data sources.
Founding story
Aledade was founded in 2014 on the premise that value-based primary care can be scaled by giving primary care accountability for total cost and quality of care, according to co-founder and CEO Farzad Mostashari. A third-party profile states it was founded by Farzad Mostashari, Mat Kendall and Edwin Miller, and that Mostashari, formerly head of the Office of the National Coordinator for Health Information Technology at HHS, started the company with seed funding from Venrock after concluding that small independent primary care physicians were well positioned for value-based care but lacked tools and support.
Business model
Aledade contracts with payers on behalf of networks of primary care organizations and shares in the savings generated when those practices reduce total cost of care while meeting quality targets; the company states its model succeeds only when its practices succeed. Practices retain ownership and independence rather than being acquired.
Revenue is derived from value-based care contracts with Medicare (including the Medicare Shared Savings Program), Medicare Advantage plans, Medicaid and commercial payers, with shared savings distributed to participating practices. Reported revenue exceeded $475 million for 2022, more than 50% growth over 2021.
Traction
As of the current website, more than 3,000 primary care partners across 46 states and D.C. and more than 3 million lives under management, with 84% of decision-makers rating its products and services as high quality in a 2025 customer experience survey. At the time of the 2023 Series F, the network covered more than 1,500 practices in 45 states and D.C., more than 150 value-based care contracts covering over two million patients and more than $20 billion in total health care spending, including more than one million Medicare Shared Savings Program patients and nearly 250,000 Medicare Advantage patients, with more than $1.7 billion in cumulative savings to the U.S. health care system through 2022.
Latest developments
The company has announced the hiring of a new chief technology officer and a chief scientist to accelerate AI innovation, published a case study on community hypertension management, and is running the Aledade Access remote monitoring program tied to a CMS payment model test. A third-party profile lists a $500 million debt financing announced in December 2025.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Aledade describes itself as the largest network of independent primary care practices in the U.S. A third-party profile states that in 2023, 93% of its ACO partners earned shared savings versus a 70% national average, that five of the top 10 Medicare Shared Savings Program ACOs are Aledade affiliates, that Newsweek named it among the World's Best Digital Health Companies in 2024 for medical management, and that Forbes ranked it No. 3 among U.S. healthcare startups.
Physician-led ACO model that lets practices access data, technology and scale without selling their practice; multiple ACO track options; contracts spanning Medicare and commercial insurers rather than Medicare alone; and reported partner outcomes such as 50% more Annual Wellness Visits than the average practice in 2023 and average shared savings payments above $205,000 per partner in 2023.
Technology
A technology platform that captures, centralizes and surfaces actionable patient data at the point of care to support earlier clinical intervention and care coordination, with tooling to identify at-risk patients and close care gaps. A third-party profile describes integrations with more than 100 EHRs and over 300 external data sources. The company has announced new CTO and chief scientist appointments to accelerate AI innovation and describes providing AI tools to partner organizations. The Aledade Access program uses connected 'smart' blood pressure cuffs that transmit readings to the patient's physician, paired with SMS/phone-based health coaching.
Go-to-market
Direct partnership recruitment of primary care organizations into regional Aledade ACOs across 46 states and D.C., supported by state-level ACO options, partner spotlight case studies, a residency pipeline program (Aledade FIRST) and alliances with national and regional health plans.
Independent primary care practices, community health centers, health systems and clinics; downstream beneficiaries are their patients, including Medicare and Medicare Advantage members.
Geography
United States; headquartered in Bethesda, Maryland, with partner primary care organizations in 46 states and the District of Columbia (45 states and D.C. as of 2023).
History
Founded in 2014, Aledade raised successive venture rounds from 2014 through 2023 and grew its ACO network nationally. A third-party profile reports the 2022 acquisition of Iris Healthcare to add advance care planning to its platform, a 10-year Medicare Advantage primary care partnership with Humana, and a $3.5 billion valuation following the June 2023 $260 million Series F led by Lightspeed Venture Partners. In 2023 the company added David Blumenthal and Paul Hennessy to its board and hired Efrem Castillo as SVP for Medicare Advantage, while Mandy Cohen, then CEO of Aledade Care Solutions, left to become director of the CDC.
Risks & controversies
No controversies are described in the available sources. Sources note dependence on federal programs and CMS model design (for example, Aledade Access enrollment is limited by CMS randomized comparison-group assignment), and third-party data on scale, funding totals and valuation is inconsistent with company-reported figures.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 6
by search overlapCompanies competing with Aledade for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 10
launches, deals, and filingsA third-party profile lists a $500 million debt financing announced in December 2025.
$500M source ↗
Aledade announced the addition of a chief technology officer and chief scientist to accelerate AI innovation.
Physician-referred, Medicare-covered program providing a free connected blood pressure cuff, health coaching and data sharing with the patient's physician for conditions including hypertension, high cholesterol, diabetes/pre-diabetes and early kidney disease; operated in connection with a CMS payment model test.
Third-party profile reports Newsweek recognition in 2024 and a No. 3 Forbes ranking among U.S. healthcare startups.
Aledade announced a $260 million Series F round to accelerate network growth, enhance technology and pursue strategic acquisitions, with participation from Venrock, Avidity Partners, OMERS Growth Equity and Fidelity Management & Research Company.
$260M source ↗
Aledade added David Blumenthal, M.D., former president of the Commonwealth Fund and former U.S. National Coordinator for Health Information Technology, and Paul Hennessy, CEO of Shutterstock, to its board.
Efrem Castillo, M.D., previously SVP of clinical transformation at Optum and CMO at UnitedHealthcare Medicare Solutions, joined Aledade as senior vice president for Medicare Advantage.
Mandy Cohen, M.D., M.P.H., CEO of Aledade Care Solutions, left the company to become director of the Centers for Disease Control and Prevention.
A third-party profile reports a 10-year agreement with Humana covering Medicare Advantage primary care.
Aledade acquired Iris Healthcare to integrate advance care planning into its platform, according to a third-party company profile.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structureIn the news
▸Research sources · 8
primary sources listed
- Aledadealedade.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Aledade do?
- Physician-led value-based care company that builds and operates accountable care organizations with independent primary care practices.
- Who founded Aledade?
- Aledade was founded by Bijan Salehizadeh, Farzad Mostashari, Mat Kendall in 2014.
- Who are Aledade's investors?
- Aledade's investors include Activate Venture Partners, ARCH Venture Partners, Echo Health Ventures, GV (Google Ventures), Intrepid Growth Partners, IVP (Institutional Venture Partners), Lightspeed Venture Partners, McKesson Ventures and 4 more.
- How much funding has Aledade raised?
- Aledade has disclosed $662.6M raised across 8 of its 13 known rounds.
- Where is Aledade headquartered?
- Aledade is headquartered in Bethesda, US.

